Vol 21, No 5 (2016)
Original research articles
Published online: 2016-09-01

open access

Page views 339
Article views/downloads 223
Get Citation

Connect on Social Media

Connect on Social Media

Superior sulcus non-small cell lung carcinoma: A comparison of IMRT and 3D-RT dosimetry

Pierre Truntzer1, Delphine Antoni12, Nicola Santelmo3, Catherine Schumacher3, Pierre-Emmanuel Falcoz3, Elisabeth Quoix4, Gilbert Massard3, Georges Noël12
DOI: 10.1016/j.rpor.2016.03.006
Rep Pract Oncol Radiother 2016;21(5):427-434.

Abstract

Aim

A dosimetric study comparing intensity modulated radiotherapy (IMRT) by TomoTherapy to conformational 3D radiotherapy (3D-RT) in patients with superior sulcus non-small cell lung cancer (NSCLC).

Background

IMRT became the main technique in modern radiotherapy. However it was not currently used for lung cancers. Because of the need to increase the dose to control lung cancers but because of the critical organs surrounding the tumors, the gains obtainable with IMRT is not still demonstrated.

Material and methods

A dosimetric comparison of the planned target and organs at risk parameters between IMRT and 3D-RT in eight patients who received preoperative or curative intent irradiation.

Results

In the patients who received at least 66[[ce:hsp sp="0.25"/]]Gy, the mean V95% was significantly better with IMRT than 3D-RT (p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.043). IMRT delivered a lower D2% compared to 3D-RT (p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.043). The IH was significantly better with IMRT (p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.043). The lung V5[[ce:hsp sp="0.25"/]]Gy and V13[[ce:hsp sp="0.25"/]]Gy were significantly higher in IMRT than 3D-RT (p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.043), while the maximal dose (Dmax) to the spinal cord was significantly lower in IMRT (p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.043). The brachial plexus Dmax was significantly lower in IMRT than 3D-RT (p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.048). For patients treated with 46[[ce:hsp sp="0.25"/]]Gy, no significant differences were found.

Conclusion

Our study showed that IMRT is relevant for SS-NSCLC. In patients treated with a curative dose, it led to a reduction of the exposure of critical organs, allowing a better dose distribution in the tumor. For the patients treated with a preoperative schedule, our results provide a basis for future controlled trials to improve the histological complete response by increasing the radiation dose.

Article available in PDF format

View PDF Download PDF file